Search Results
Feb 25, 2026, 08:00 ET Parker Institute for Cancer Immunotherapy Announces Appointment of Bob Purcell as Chief Communications Officer
patient access. By integrating scientific excellence with entrepreneurial execution, PICI is reimagining how cures are made, and accelerating their path to the people who need them most. | Learn more about PICI:
More news about: Parker Institute for Cancer Immunotherapy
Feb 25, 2026, 08:00 ET Scopio Labs Achieves EU IVDR Certification for AI-Powered Full-Field Digital Morphology Platforms
25, 2026 /PRNewswire/ -- Scopio Labs today announced it has achieved IVDR certification from BSI, a major regulatory milestone that clears the path for its AI-driven digital morphology platforms in the European Union. The certification covers the company's QMS and full technical documentation for
More news about: Scopio Labs
Feb 25, 2026, 08:00 ET UNION and Firehawk Align to Strengthen the West's Metal Parts and Energetics Production Readiness
certification readiness. Together, the teams are developing a more integrated manufacturing approach designed to strengthen readiness and streamline the path from component production through system integration.Key factsInitial focus on 155mm-related metal parts and
More news about: UNION Technologies
Feb 25, 2026, 08:00 ET Evogene Releases CEO Letter to Shareholders
technology engine, disciplined capital allocation, and strong strategic partnerships, we believe Evogene is now positioned on a clear, more focused path toward sustainable value creation.Thank you for your continued trust and support.Sincerely,Ofer Haviv President and
More news about: Evogene
Feb 25, 2026, 07:30 ET BTQ Technologies Announces New Quantum Hardware Commercialization Hub in New York City and Key Engineering Hires to Accelerate QCIM
cryptography.Accelerating Execution From Architecture to SiliconThis concentration of talent is intended to materially shorten BTQ's path from QCIM architecture to validated and commercial-ready silicon. The group's combined experience across quantum control hardware, advanced ASIC
More news about: BTQ Technologies Corp.
Feb 25, 2026, 06:30 ET Hut 8 Reports Fourth Quarter and Full Year 2025 Results
Hut 8 has secured a clear path to ownership through either: (i) an exclusivity agreement that prevents the sale of designated land and power capacity to another party or (ii) a tendered interconnection agreement, confirming a viable path to securing power and infrastructure
More news about: Hut 8 Corp.
Feb 25, 2026, 06:00 ET BMO Financial Group Reports First Quarter 2026 Results
expectations," said Darryl White, CEO of BMO Financial Group."Through disciplined execution of our strategy we are making meaningful progress on the clear path we set to elevate returns and drive profitable earnings growth as we focus on delivering value for our clients and shareholders," concluded Mr. White.Concurrent
More news about: BMO Financial Group
Feb 25, 2026, 06:00 ET BMO Financial Group Reports First Quarter 2026 Results
expectations," said Darryl White, CEO of BMO Financial Group."Through disciplined execution of our strategy we are making meaningful progress on the clear path we set to elevate returns and drive profitable earnings growth as we focus on delivering value for our clients and shareholders," concluded Mr. White.Concurrent
More news about: BMO Financial Group
Feb 25, 2026, 05:00 ET Gcore integrates NVIDIA Dynamo to deliver high-performance, cost-efficient AI inference as a fully managed service
big performance and cost penalties. By integrating Dynamo as a managed service in Gcore, we bring advanced GPU optimization directly into the runtime path so customers see higher effective throughput and steadier tail latency, without operating the complexity themselves."Beyond performance gains,
More news about: Gcore
Feb 24, 2026, 19:28 ET New National Poll Shows Immigration Enforcement Is Driving Voters Away from Republicans Ahead of 2026 Midterms
enforcement (12%).Large majorities support a path to citizenship and legal status.73% support a path to citizenship for undocumented immigrants already in the U.S. (44% strongly), and 72% support a path to legal residency under the same conditions.The
More news about: Unite Here
Feb 24, 2026, 18:52 ET QURE Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages QURE Investors with Losses to Contact the Firm
adequate to provide the primary evidence in support of a BLA submission." Although the Company "plan[ned] to urgently interact with the FDA to find a path forward for the timely accelerated approval of AMT-130," uniQure admitted that "the timing of the BLA submission for AMT-130 is now unclear." On this
More news about: Kessler Topaz Meltzer & Check, LLP
Feb 24, 2026, 16:47 ET Fermi America™ Announces Fourth Quarter 2025 Earnings Call on March 30, 2026
by rapid execution and major milestone advancement across Project Matador's 11 GW private energy campus, provide an update on the company's critical path to scale, and answer questions directly from investors.Webcast & Conference Call DetailsDate: Monday,
More news about: Fermi America
Feb 24, 2026, 16:30 ET Best AI Domain Generator (2026): Network Solutions Named Leading AI Domain Name Generator for Businesses by Expert Consumers
Solutions as a leading AI domain name generator for businesses, reflecting rising demand for tools that simplify domain discovery and streamline the path from idea to registration. Best AI Domain Generator
More news about: ExpertConsumers.org
Feb 24, 2026, 16:23 ET Jonathan De Armas From De Armas Law Named "Attorney of the Year" by Orlando Style Magazine
to explain each step of the process, and readiness to pursue creative solutions rather than defaulting to lengthy, expensive litigation when a better path exists.Practice focus and client impact:
More news about: De Armas Law Firm
Feb 24, 2026, 16:15 ET HOTH THERAPEUTICS ACCELERATES HT-001 TRIAL ENROLLMENT WITH NEW CLINICAL SITE AS PATIENT DEMAND INCREASES
FDA-compliant research infrastructure and a new South Florida patient population to the CLEER-001 network. For Hoth, it means faster enrollment, a faster path to a complete data set, and a faster road to the regulatory milestones that matter."The addition of Regis Clinical Research is a direct response
More news about: Hoth Therapeutics, Inc.
Feb 24, 2026, 16:15 ET Talos Energy Announces Fourth Quarter and Full-Year 2025 Results
plan to appraise in the second quarter of 2026. Our accomplishments in 2025 underscore the momentum we are building and reinforce our confidence in the path ahead. In 2026, we are looking forward to the opportunities to continue investing for the future and executing our strategy with discipline and focus."
More news about: Talos Energy
Feb 24, 2026, 16:05 ET Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2025 Financial Results and Provides 2026 Financial Guidance
with respect to its products and product candidates and the potential of the Company's products and product candidates and the potential regulatory path related thereto; including zanidatamab's potential to be the HER2-targeted agent of choice in HER2+ 1L GEA, regardless of PD-L1 status, and to reshape
More news about: Jazz Pharmaceuticals plc
Feb 24, 2026, 16:05 ET Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2025 Financial Results and Provides 2026 Financial Guidance
with respect to its products and product candidates and the potential of the Company's products and product candidates and the potential regulatory path related thereto; including zanidatamab's potential to be the HER2-targeted agent of choice in HER2+ 1L GEA, regardless of PD-L1 status, and to reshape
More news about: Jazz Pharmaceuticals plc
Feb 24, 2026, 15:55 ET Study Links Poor Sleep to Increased Risky Behavior Among Autistic People
Catalight Catalight breaks down barriers and biases to create a more equitable world so people with developmental disabilities can choose their path to care. Catalight provides access to innovative, individualized care services, clinical research and advocacy — all powered by intelligent technology.
More news about: Catalight Foundation, a California non-profit corporation
Feb 24, 2026, 15:00 ET Faith, Finances, and Freedom: Full Bloom Financial® Featured on Empowered with Meg Ryan
will also explain how Biblically Responsible Investing (BRI) can provide a way for individuals to align their portfolio with their faith, offering a path to stewardship that feels both financially sound and spiritually aligned. Viewers will learn about the significance of working with a fiduciary advisor
More news about: Empowered with Meg Ryan
Feb 24, 2026, 12:26 ET Cox Business Teams Up with Best-Selling Author Gene Marks for "The AI Business Playbook"
Why Businesses Need a Practical Path Through the AI ShiftAs AI reshapes the business landscape at unprecedented speed, leaders are feeling the pressure to keep pace. But the
More news about: Cox Communications
Feb 24, 2026, 12:15 ET Illumina launches TruPath Genome, setting a new standard in genomic insight
of at least 30x coverage with single-use flow cell, which is critical in clinical research.Data presented at AGBT illustrates a short-read path to long-distance insightData presented today at AGBT and in previous
More news about: Illumina, Inc.
Feb 24, 2026, 11:47 ET Myrias Optics Announces $2.1 Million Seed 1 Financing to Accelerate Commercialization of Wafer-Level Metaoptics
nanoimprinting technology enables precision optical components with industry-leading material performance, strong yield characteristics, and a clear path to production-scale deployment.For more information:
More news about: Myrias Optics
Feb 24, 2026, 10:58 ET Oncology Market Set to Nearly Triple: Here Are Five Companies Leading the Charge
gastrointestinal study after generating sufficient clinical and translational data to chart a clear path toward FDA approval.The promising efficacy signal in GOBLET Cohort 4 has defined a clear registrational path for pelareorep in second-line and later squamous cell anal cancer, a setting where available
More news about: USA News Group
Feb 24, 2026, 10:49 ET Consegna Pharma Highlights Innovative Modeling and Simulation Strategy as FDA Concurs with Regulatory Pathway for CP217 to Prevent Fentanyl Epidemic Deaths
reliance on large, expensive, and time-consuming clinical efficacy trials. With the FDA's guidance, we now have a clearly defined, capital‑efficient path to NDA filing and we look forward to exploring strategic partnerships to maximize its impact against the synthetic opioid epidemic.""Our streamlined
More news about: Consegna Pharma Inc.